We are very excited to announce the launch of our new biosimilars product line, InVivoSIM™! This new class of antibodies is a great addition to our current portfolio of in vivo functional grade research antibodies.
Our InVivoSIM™ non-therapeutic antibodies are research-grade biosimilar monoclonal antibodies that have the same active biological components as the original therapeutic antibodies. Biosimilars make it possible to study the biological effects of a drug without the need to source an expensive pharmaceutical-grade therapeutic. Our InVivoSIM™ biosimilar antibodies feature greater than 95% purity and are free of preservatives, stabilizers, and carrier proteins. They are screened for murine pathogens and protein aggregation, feature binding validation via Immunoblot and are guaranteed to contain less than 1 endotoxin unit per milligram. InVivoSIM™ antibodies are for research use only (RUO) and are not for therapeutic use. |